NHS rolls out cancer vaccine trials at 30 UK sites with BioNTech collaboration. LONDON, June 1: The United Kingdom's National Health Service (NHS) is expediting patient enrollment for its upcoming personalized cancer vaccine trials, leveraging cutting-edge mRNA technology. According to The Guardian, patients who meet the eligibility criteria can quickly join the trials by consenting…